EMM Disclosure -CFD
2003年7月9日 - 7:22PM
ＲＮＳを含む英国規制内ニュース （英語）
RNS Number:3390N
UBS AG (EMM)
09 July 2003
FORM 38.5 (SUMMARY)
Lodge with Company Announcements Office and the Panel. Use a separate form for each class of securities in which
dealings have been made.
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Name of EMM UBS AG
....................................................................................
Date of disclosure 09 July 2003
....................................................................................
Contact Name Brenton Amedee
....................................................................................
Telephone number 020-7568 4981
....................................................................................
Please see attached disclosure of dealings under Rule 38.5 in the securities of the following companies:
British Biotech Plc
British Biotech Contract For Difference
McCarhty & Stone Contract For Difference
Powderject Contract For Difference
Vernalis Contract For Difference
_______________________________________
AMENDMENT
If the attached Rule 38.5 disclosure is to amend a previous disclosure, please state which element(s) of previous
disclosure was incorrect:
In the case of option business or dealings in derivatives full details should be given on a separate sheet so
that the nature of the dealings can be fully understood. For options this should include the number of securities
under option, the exercise period (or in the case of exercise, the exercise date), the exercise price and any
option money paid or received. For derivatives this should include, at least, the number of reference securities
to which they relate (when relevant), the maturity date (or if applicable the closing out date) and the reference
price.
For full details of disclosure requirements see Rules 8 and 38 of the Code. If in doubt contact the Monitoring
Section of the Panel, Tel No: 020-7638 0129.
FORM 38.5
CONNECTED EXEMPT MARKET-MAKERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in BRITISH BIOTECH PLC (name of company)
...........................................
Class of Security ORD GBP 0.10
...............................................................
Date of disclosure 9-Jul-03
...............................................................
Date of dealing 8-Jul-03
...............................................................
Name of EMM UBS AG
...............................................................
Name of offeree / offeror with whom connected VERNALIS GROUP PLC
....................................
Total Number of securities bought 200,000
........................
Highest price paid* 0.65 GBP
........................
Lowest price paid* 0.62 GBP
........................
Total number of securities sold 100,000
........................
Highest price received* 0.61 GBP
........................
Lowest price received* 0.61 GBP
Rule 38.5 (CFD)
CONNECTED EXEMPT MARKET-MAKERS/EXEMPT PRINCIPAL TRADERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in Contract for Differences ("CFD") referenced to...British Biotech Plc,
Ord 0.10
Date of Disclosure: 09 July 2003
Date of Dealing 08 Jul 2003
Name of EMM/EPT... UBS AG
Name of offeree / offeror with whom connected Vernalis Group Plc
Product Type.........(long/short) CFD Long
Maturity Date 03 Feb 2004
Writing of CFD
Number of securities to which the CFD is referenced 0
CFD reference price: (High) 0 GBP............................(Low) 0 GBP......
.....................
Closing out of CFD
Number of securities to which the CFD is referenced 150,000
CFD reference price: (High) 0.62 GBP (Low) 0.62 GBP
Further disclosure should be made where necessary so that the nature of the dealings can be fully understood.
Rule 38.5 (CFD)
CONNECTED EXEMPT MARKET-MAKERS/EXEMPT PRINCIPAL TRADERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in Contract for Differences ("CFD") referenced to...British Biotech Plc,
Ord 0.10
Date of Disclosure: 09 July 2003
Date of Dealing 08 Jul 2003
Name of EMM/EPT... UBS AG
Name of offeree / offeror with whom connected Vernalis Group Plc
Product Type.........(long/short) CFD Short
Maturity Date 08 Apr 2004
Writing of CFD
Number of securities to which the CFD is referenced 100,000
CFD reference price: (High) 0.61 GBP............................(Low) 0.61GBP...
........................
Closing out of CFD
Number of securities to which the CFD is referenced 0
CFD reference price: (High) 0 GBP (Low) 0 GBP
Further disclosure should be made where necessary so that the nature of the dealings can be fully understood.
Rule 38.5 (CFD)
CONNECTED EXEMPT MARKET-MAKERS/EXEMPT PRINCIPAL TRADERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in Contract for Differences ("CFD") referenced to...British Biotech Plc,
Ord 0.10
Date of Disclosure: 09 July 2003
Date of Dealing 08 Jul 2003
Name of EMM/EPT... UBS AG
Name of offeree / offeror with whom connected Vernalis Group Plc
Product Type.........(long/short) CFD Long
Maturity Date 08 Apr 2004
Writing of CFD
Number of securities to which the CFD is referenced 50,000
CFD reference price: (High) 0.65 GBP............................(Low) 0.65 GBP
...........................
Closing out of CFD
Number of securities to which the CFD is referenced 0
CFD reference price: (High) 0 GBP (Low) 0 GBP
Further disclosure should be made where necessary so that the nature of the dealings can be fully understood.
Rule 38.5 (CFD)
CONNECTED EXEMPT MARKET-MAKERS/EXEMPT PRINCIPAL TRADERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in Contract for Differences ("CFD") referenced to...McCarthy & Stone
Plc, ord 0.20
Date of Disclosure: 09 July 2003
Date of Dealing 08 July 2003
Name of EMM/EPT... UBS AG
Name of offeree / offeror with whom
connected McCarthy & Stone Plc
Product Type.........(long/short) CFD Long
Maturity Date 15 Apr 2004
Writing of CFD
Number of securities to which the CFD is referenced 0
CFD reference price: (High) 0 GBP............................(Low) 0 GBP......
.....................
Closing out of CFD
Number of securities to which the CFD is referenced 100,000
CFD reference price: (High) 5.08 GBP (Low) 5.08 GBP
Further disclosure should be made where necessary so that the nature of the dealings can be fully understood.
Rule 38.5 (CFD)
CONNECTED EXEMPT MARKET-MAKERS/EXEMPT PRINCIPAL TRADERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in Contract for Differences ("CFD") referenced to...Powderject
Pharmaceuticals Plc, ord 0.10
Date of Disclosure: 09 July 2003
Date of Dealing 08 July 2003
Name of EMM/EPT... UBS AG
Name of offeree / offeror with whom
connected Chiron
Product Type.........(long/short) CFD Long
Maturity Date 30 Jan 2004
Writing of CFD
Number of securities to which the CFD is referenced 0
CFD reference price: (High) 0 GBP............................(Low) 0 GBP......
.....................
Closing out of CFD
Number of securities to which the CFD is referenced 200,000
CFD reference price: (High) 5.50 GBP (Low) 5.50 GBP
Further disclosure should be made where necessary so that the nature of the dealings can be fully understood.
Rule 38.5 (CFD)
CONNECTED EXEMPT MARKET-MAKERS/EXEMPT PRINCIPAL TRADERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in Contract for Differences ("CFD") referenced to...Vernalis Group Plc,
ord 0.10
Date of Disclosure: 09 July 2003
Date of Dealing 08 July 2003
Name of EMM/EPT... UBS AG
Name of offeree / offeror with whom
connected VERNALIS GROUP PLC
Product Type.........(long/short) CFD Short
Maturity Date 04 Apr 2004
Writing of CFD
Number of securities to which the CFD is referenced 0
CFD reference price: (High) 0 GBP............................(Low) 0 GBP......
.....................
Closing out of CFD
Number of securities to which the CFD is referenced 258,000
CFD reference price: (High) 0.46 GBP (Low) 0.46 GBP
Further disclosure should be made where necessary so that the nature of the dealings can be fully understood.
Rule 38.5 (CFD)
CONNECTED EXEMPT MARKET-MAKERS/EXEMPT PRINCIPAL TRADERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in Contract for Differences ("CFD") referenced to... Vernalis Group Plc,
ord 0.10
Date of Disclosure: 09 July 2003
Date of Dealing 08 July 2003
Name of EMM/EPT... UBS AG
Name of offeree / offeror with whom
connected VERNALIS GROUP PLC
Product Type.........(long/short) CFD Long
Maturity Date 08 Apr 2004
Writing of CFD
Number of securities to which the CFD is referenced 200,000
CFD reference price: (High) 0.46 GBP............................(Low) 0.46 GBP
...........................
Closing out of CFD
Number of securities to which the CFD is referenced 0
CFD reference price: (High) 0 GBP (Low) 0 GBP
Further disclosure should be made where necessary so that the nature of the dealings can be fully understood.
Rule 38.5 (CFD)
CONNECTED EXEMPT MARKET-MAKERS/EXEMPT PRINCIPAL TRADERS:
DISCLOSURE UNDER RULE 38.5 OF THE CITY CODE ON TAKEOVERS AND MERGERS
Dealing in Contract for Differences ("CFD") referenced to...WPP Group Plc, ord
0.10
Date of Disclosure: 09 July 2003
Date of Dealing 08 July 2003
Name of EMM/EPT... UBS AG
Name of offeree / offeror with whom
connected CORDIANT COMMUNICATIONS
GROUP PLC
Product Type.........(long/short) CFD Long
Maturity Date 08 Apr 2004
Writing of CFD
Number of securities to which the CFD is referenced 500,000
CFD reference price: (High) 5.05 GBP............................(Low) 5.05 GBP
...........................
Closing out of CFD
Number of securities to which the CFD is referenced 0
CFD reference price: (High) 0 GBP (Low) 0 GBP
Further disclosure should be made where necessary so that the nature of the dealings can be fully understood.
This information is provided by RNS
The company news service from the London Stock Exchange
END
EMMUKURROURBRAR